Go to main page

BioDuro COVID-19 Update

BioDuro Tenacity Manages Challenges of COVID-19 Across The Globe (Update: March 25, 2020)

BioDuro is open for business Globally. Thankfully, to date, none of our employees in the US or China have been diagnosed with COVID-19 and there is no plan for any closures for BioDuro at this time.

In fact, BioDuro has become a relied upon CRO/CDMO resource for many partners facing difficulties in operations, including facility shutdowns. We are here to help in the long run, and in the short run. Contact us to keep your programs advancing.

China Operation
BioDuro China operations is back to work at 97% capacity, and we are currently hiring more scientists to meet growing demand. Our team has pulled out all the stops to create a safe and productive workplace. We are proud to be showcased by local news as an example of conscientious employer focused on staff health & safety by Beijing policy makers.

Following the Spring Festival, our Beijing and Shanghai sites resumed operations on February 3rd and February 10th, 2020 respectively. Our scientists have resumed their daily research work, and we are doing everything possible, including overtime and weekends, to restore schedules and catch up on any delayed project.

Senior management has provided the leadership needed to ensure all support departments, including purchasing and logistics, are coordinating with project teams to ensure research progress and restoration of schedule.

With the gradual stabilization and improvement of the epidemic, we will continue to do our utmost to reduce the delay and inconvenience caused by this epidemic.

US Operation
Our facilities are open, & we have received exemption under Presidential Policy Directive-21 (PPD-21), as one of the 16 critical infrastructure sections, to continue manufacturing for our clients” drug product needs. However, we continue to take precautionary steps as part of our business continuity plan to minimize potential disruptions to the important work we do:

  • Implemented work from home plans for US staff whose roles do not require them to be on site.
  • Leadership & colleagues use CDC good hygiene best practice guidelines.
  • We are monitoring staff temperature on arrival.
  • Employees who feel ill are required to stay home.
  • Increased on-site cleaning/disinfecting.
  • Increased the availability of hand sanitizing agents throughout the site (including bulk manufacturing of our own hand sanitizer due to temporary retail shortages).
  • Mandated US personnel avoid international travel

Where our clients have imposed restrictions for visits to their sites, we wish to honor their policies & will instead facilitate meetings via teleconference or video conferencing.

We thank all our employees for their dedication and tenacity as we all continue to work together through these challenging times, to support our clients and ultimately patients.